Implantica
Implantica publishes Interim Report January - September 2026 (Q3)
FDA approval secured and first U.S. patients treated at USC Significant events in the third quarter of 2026 FDA Premarket Approval (PMA) granted for…
Company newsroom
1 releases
FDA approval secured and first U.S. patients treated at USC Significant events in the third quarter of 2026 FDA Premarket Approval (PMA) granted for…